Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes.
D000328:Adult; D000367:Age Factors; D000368:Aged; D002386:Cataract / Q000139:chemically induced; D002746:Chlorpromazine / Q000009:adverse effects; D003315:Cornea / Q000473:pathology; D005069:Evaluation Studies as Topic; D005128:Eye Diseases / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D007498:Iris / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000009:adverse effects*; D011618:Psychotic Disorders / Q000188:drug therapy; D012737:Sex Factors; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014966:Xanthenes / Q000009:adverse effects*
D010640:Phenothiazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D002746:Chlorpromazine